These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9838314)

  • 1. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study.
    Kim MS; Kim YS; Kim SI; Lee JW; Moon JI; Park K
    Transplant Proc; 1998 Nov; 30(7):2977-8. PubMed ID: 9838314
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival.
    Süsal C; Dörr C; Groth J; May G; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
    Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretransplant IgA-anti-hinge and IgA-anti-Fab autoantibody activity is associated with good kidney graft survival.
    Süsal C; Kröpelin M; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Oct; 27(5):2663-5. PubMed ID: 7482869
    [No Abstract]   [Full Text] [Related]  

  • 5. Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Wiesel M; Schönemann C; Groth J; Carl S; Staehler G; May G; Opelz G
    Transplant Proc; 1997; 29(1-2):1444-6. PubMed ID: 9123373
    [No Abstract]   [Full Text] [Related]  

  • 6. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
    Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Solgi G
    Transplant Proc; 2015 May; 47(4):1110-3. PubMed ID: 26036531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study.
    Süsal C; Döhler B; Opelz G
    Transplantation; 2000 Apr; 69(7):1337-40. PubMed ID: 10798750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural IgA-anti-F(ab')2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope.
    Terness P; Navolan D; Moroder L; Siedler F; Weyher E; Kohl I; Dufter C; Welschof M; Drugarin D; Schneider F; Opelz G
    J Immunol; 1996 Nov; 157(9):4251-7. PubMed ID: 8892664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies to explain high renal allograft survival in IgA nephropathy patients.
    Lim EC; Chia D; Gjertson DW; Koka P; Terasaki PI
    Transplantation; 1993 May; 55(5):996-9. PubMed ID: 8497914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA class antibodies and flow cytometric cross-matching in renal transplantation.
    Doran TJ; Süsal C; Opelz G; Geczy AF
    Transplantation; 1999 Jan; 67(2):309-14. PubMed ID: 10075600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher immunoglobulin A nephropathy recurrence in related-donor kidney transplants: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Okada D; Unagami K; Kakuta Y; Iizuka J; Takagi T; Shirakawa H; Omoto K; Ishida H; Tanabe K;
    Int J Urol; 2019 Sep; 26(9):903-909. PubMed ID: 31328329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
    Berthoux F; Suzuki H; Mohey H; Maillard N; Mariat C; Novak J; Julian BA
    J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies.
    Jackson S; Montgomery RI; Julian BA; Galla JH; Czerkinsky C
    Clin Immunol Immunopathol; 1987 Nov; 45(2):208-13. PubMed ID: 3499275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies directed at Fab of IgA in the sera of normal individuals and IgA nephropathy patients.
    Jackson S; Montgomery RI; Mestecky J; Julian BA; Galla JH; Czerkinsky C
    Adv Exp Med Biol; 1987; 216B():1537-44. PubMed ID: 3501235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
    Lorenz KJ; Süsal C; Opelz G; Maier H
    Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer.
    Süsal C; Maier H; Lorenz K; Opelz G
    Int J Cancer; 1994 Apr; 57(1):47-50. PubMed ID: 8150540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplant serum IgG-anti-F(ab')2gamma activity and kidney graft outcome: comparison of results obtained at two centers.
    Süsal C; Groth J; Oberg HH; Terness P; May G; Staehler G; Opelz G
    Transpl Int; 1992; 5 Suppl 1():S625-6. PubMed ID: 14621892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.